Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.14.11.68 extracted from

  • Romani, M.; Daga, A.; Forlani, A.; Pistillo, M.P.; Banelli, B.
    Targeting of histone demethylases KDM5A and KDM6B inhibits the proliferation of temozolomide-resistant glioblastoma cells (2019), Cancers (Basel), 11, 878 .
    View publication on PubMedView publication on EuropePMC
Search for more literature for 1.14.11.68

Inhibitors

Inhibitors Comment Organism Structure
GSKJ4 inhibitor is active against native and temozolomide-resistant glioblastoma cells, albeit at at a lower effcacy than JIB 04, inhibitor of lysine demethylase KDM5A, EC 1.14.11.67. GSK J4 and JIB 04 strongly synergize and are a potent combination against temozolomide-resistant glioblastoma cells. GSK J4 does not synergize with temozolomide Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens O15054 isoform KDM6B
-

Synonyms

Synonyms Comment Organism
KDM6B
-
 Homo sapiens